MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 16

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 28, 2014; 20(16): 4723-4729
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4723

Full Size Figure Download Figure

Figure 1 Patient selection process. HCC: Hepatocellular carcinoma; CHB: Chronic hepatitis B.

Citation: Ji XF, Fan YC, Gao S, Yang Y, Zhang JJ, Wang K. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma. World J Gastroenterol 2014; 20(16): 4723-4729
URL: https://www.wjgnet.com/1007-9327/full/v20/i16/4723.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i16.4723

Ji XF, Fan YC, Gao S, Yang Y, Zhang JJ, Wang K. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma. World J Gastroenterol 2014; 20(16): 4723-4729 [PMID: 24782625 DOI: 10.3748/wjg.v20.i16.4723]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.